Article
MYC levels govern hematopoietic tumor type and latency in transgenic mice.
Blood - 15 Jul 2006
Smith Darrin P, Bath Mary L, Metcalf Donald, Harris Alan W, Cory Suzanne
Abstract excerpt
Deregulated MYC expression has been implicated in the etiology of many human cancers, including hematopoietic malignancies. To explore the impact of widespread constitutive MYC expression in the hematopoietic compartment, we have used a vector containing regulatory elements of the Vav gene to generate transgenic mice. VavP-MYC mice are highly tumor-prone and the level of MYC was found to influence both the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
